Multiple Myeloma: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering’s current clinical trials for multiple myeloma and related plasma cell diseases.

Showing 22 trials
Title Investigator
A Phase I Study of BMS-936558 in Patients with Relapsed or Refractory Hematologic Cancers
[Protocol 12-142] 		Lesokhin, Alexander, MD
A Phase I Study of CUDC-907 in Patients with Relapsed or Refractory Lymphoma or Multiple Myeloma
[Protocol 13-045] 		Younes, Anas, MD
A Phase I Study of IPI-145 in Patients with Advanced Hematologic Cancers
[Protocol 12-088] 		Horwitz, Steven, MD
A Phase I Study of WT1-Specific Donor-Derived T Cells in Patients with Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia after T-Cell-Depleted Allogeneic Stem Cell Transplantation
[Protocol 12-175] 		Koehne, Guenther, MD, PhD
A Phase I/II Study of Cabozantinib (XL184) in Patients with Recurrent or Persistent Myeloma
[Protocol 12-240] 		Giralt, Sergio, MD
A Phase I/IIA Study of Carfilzomib plus High-Dose Melphalan Before Autologous Stem Cell Transplant in Patients with Multiple Myeloma
[Protocol 12-144] 		Landau, Heather, MD
A Phase IB Study of SAR650984 with Lenalidomide and Dexamethasone to Treat Recurrent or Persistent Multiple Myeloma
[Protocol 13-006] 		Lendvai, Nikoletta, MD
A Phase IB/IIA Study of ABT-888 in Combination with Bendamustine with or without Rituximab in Patients with Lymphoma, Multiple Myeloma, and Solid Tumors
[Protocol 10-174] 		Gerecitano, John, MD, PhD
A Phase IB/IIA Study of Romidepsin plus Lenalidomide in Adults with Relapsed or Refractory Lymphoma and Myeloma
[Protocol 12-170] 		Horwitz, Steven, MD
A Phase II Study of Bortezomib/Dexamethasone Followed by Lenalidomide in Nonresponders as Initial Treatment for Multiple Myeloma
[Protocol 13-064] 		Hassoun, Hani, MD
A Phase II Study of Bulk Versus Fractionated Stem Cell Infusions in Patients with Hematologic Cancers Undergoing Stem Cell Transplantation
[Protocol 12-016] 		Giralt, Sergio, MD
A Phase II Study of Lenalidomide Intensification in Patients with Asymptomatic Multiple Myeloma that Has Progressed with Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation
[Protocol 11-107] 		Hassoun, Hani, MD
A Phase II Study of Pomalidomide plus Autologous Stem Cell Transplantation versus Pomalidomide/Dexamethasone in Patients with Multiple Myeloma
[Protocol 12-138] 		Giralt, Sergio, MD
A Phase II Study of Siltuximab in Patients with High-Risk Smoldering Multiple Myeloma
[Protocol 12-068] 		Lesokhin, Alexander, MD
A Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
[Protocol 12-131] 		Hyman, David, MD
A Phase II Trial of Transplants from HLA-Compatible Donors with T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System for the Treatment of Patients with Hematologic Malignancies and Disorders
[Protocol 10-050] 		O'Reilly, Richard, MD
A Phase III Study of Lenalidomide, Bortezomib, and Dexamethasone Combination Treatment with or without Peripheral Stem Cell Transplantation in the Initial Management of Multiple Myeloma
[Protocol 12-018] 		Hassoun, Hani, MD
A Pilot Study of Acupuncture to Control Symptoms in Patients Receiving Stem Cell Transplantation for Multiple Myeloma
[Protocol 13-038] 		Deng, Gary, MD, PhD
A Pilot Study of Bortezomib/Dexamethasone Followed by Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone for the Initial Treatment of MIDD Associated with Multiple Myeloma and Amyloidosis
[Protocol 11-061] 		Hassoun, Hani, MD
A Pilot Study of the Wilms' Tumor 1 (WT1) Analog Peptide Vaccine in Patients with Multiple Myeloma after Autologous Stem Cell Transplantation
[Protocol 12-288] 		Koehne, Guenther, MD, PhD
A Study of Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post-Transplantation Donor Lymphocyte Infusions for Patients with Relapsed or High-Risk Multiple Myeloma
[Protocol 10-051] 		Koehne, Guenther, MD, PhD
A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma
[Protocol 09-171] 		Landau, Heather, MD
Recommended Links

Making an Appointment

Contact our Physician Referral Service to schedule a consultation with a Memorial Sloan-Kettering physician in Manhattan or at one of our suburban regional cancer centers.

Learn more »

Other Useful Information